TABLE 2.

List of analytes significantly associated with the 2 years composite endpoint of FVC decline >10%, DLCO decline >15% or death.

Analyte	Adj. Hazard Ratio	Adj. p-Value	Class
Diacylglyceride (16:0_16:1)	0.51	0.010	Diglycerides
Diacylglyceride (18:1_18:3)	1.73	0.041	Diglycerides
Octadecenoic acid	0.54	0.018	Fatty acids
Dehydroepiandrosterone sulfate	0.57	0.031	Hormones and related
Lysophosphatidylcholine a C18:0	0.48	0.006	Lysophosphatidylcholines
Lysophosphatidylcholine a C16:1	0.52	0.013	Lysophosphatidylcholines
Hypoxanthine	0.60	0.044	Nucleobases and related
Phosphatidylcholine ae C42:5	1.74	0.036	Phosphatidylcholines
Phosphatidylcholine ae C44:6	1.70	0.039	Phosphatidylcholines
Triacylglyceride (16:1_34:1)	0.50	0.007	Triglycerides
Triacylglyceride (16:1_32:0)	0.52	0.013	Triglycerides
Triacylglyceride (16:1_34:0)	0.57	0.028	Triglycerides
Triacylglyceride (16:1_34:3)	0.58	0.038	Triglycerides
Triacylglyceride (16:1_32:2)	0.59	0.038	Triglycerides
Triacylglyceride (17:1_34:1)	0.60	0.043	Triglycerides
Choline	0.51	0.010	Vitamins and cofactors